Nathan Buzza.

Operating history

Nathan founded CommtechWireless in 1992. Over sixteen years it grew into a global supplier of medical-grade wireless communications platforms with deployments across fifty-three countries and approximately 7,500 customer sites. The business was sold to Amcom in 2008. In 2011, Amcom's US operation was acquired by USA Mobility (now Spok, NASDAQ:SPOK) for US$163.3m.

Subsequent operating engagements include Alcidion (ASX:ALC), where Nathan, as a director of the private company, led the reverse takeover that listed it on the ASX in February 2016, and served as Executive Director of the listed entity from February 2016 to July 2017; ResApp Health (ASX:RAP), where he served as a Non-Executive Director from December 2017 to March 2020, thirty months before Pfizer (NYSE:PFE) acquired the company by scheme of arrangement on 26 September 2022; and Azure Healthcare (ASX:AZV, now Austco Healthcare, ASX:AHC), where he was a cornerstone investor and then Executive Vice President (2012 to 2014) while the share price moved from 3.3¢ to 34¢, before the position was divested.

The Allure mandate

Allure Capital was founded in 2011 with capital from the CommtechWireless exit. It operates as a single-principal family office running two strategies: an active medtech book — direct investments into Australian healthcare-software, medical-device and clinical-technology businesses — and a passive long-term public-markets allocation. I review every active proposal personally and answer my own correspondence. The seven investment criteria have not changed since July 2016 and explain about ninety-five percent of why most proposals don't go further than the first meeting.

Outside the firm

I also operate Illuminati Magic, an electronic-mentalism business serving professional performers across more than eighty countries. The business is unrelated to Allure's healthcare mandate. It is noted here for completeness.